Blog - Page 1893 of 5721

MondayOct 21, 2019 10:10 am

Endonovo Therapeutics Inc. (ENDV) Appoints Strategic Advisor to the CEO to Explore Growth Opportunities

The new strategic advisor, Dr. William Li, is a globally recognized medical professional One of Li’s primary specialties is the identification of unmet medical market needs that can be addressed through technological advances Endonovo is working to develop solutions for major therapeutic needs, especially in regard to pain management Its Electroceutical® SofPulse® is clinically proven to provide post-operative pain relief and speed up recovery On September 30, 2019, Endonovo Therapeutics Inc. (OTCQB: ENDV), a commercial-stage developer of innovative medical devices, announced the appointment of Dr. William Li as a strategic advisor to the CEO. The role of Li would be…

MondayOct 21, 2019 9:39 am

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Achieves Stabilized Production, Sales of Heavy Oil from Asphalt Ridge Facility

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), a fully integrated surface oil sands clean recovery mining oil company with proprietary technology, today announced that it has achieved stabilized production rates and sales of heavy oil from its Asphalt Ridge Facility in Utah. According to the update, the company has achieved the following since re-commissioning the plant in September 2019: Cumulative sales of 1,000 barrels of heavy oil; stabilized production rate of 200 bbl/per day from the facility’s current daily 12 hour shift; and oil quality (namely, clay percent and oil thickness) to meet the requirements of specific buyers. Production numbers are…

FridayOct 18, 2019 3:16 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Utilizing Artificial Intelligence, Smart Tumor Profiling to Augment Clinical Outcomes

Predictive Oncology (NASDAQ: POAI), a developer of highly adaptable assessment methods for cancer patients to help guide personalized treatments, employs its proprietary smart tumor profiling and artificial intelligence (“AI”) platform to predict tumor drug response and improve clinical outcomes for cancer patients. An article discussing the company’s activities further reads, “Last year, POAI, then known as Precision Therapeutics, formed TumorGenesis to focus on innovative ways to create improved patient-derived (PDx) tumor models. Currently, TumorGenesis is working on developing new techniques for growing tumors in the lab to generate more relevant models of the tumors that can be used to test…

FridayOct 18, 2019 3:11 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Expanding Commercialization of Wearable Pain-Management Device

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, has completed clinical trials and is currently expanding commercialization of its SofPulse® device that delivers pulsed electromagnetic frequencies for pain management. An article discussing the company reads, “In August, Endonovo announced its Q2 financial results, showing growth in both revenue and gross profits. However, since the economic potential for a safe, nonaddictive alternative to opioids is significant, the company’s continued progress as it reaches developmental and test milestones is clearly the key focus. Over the second quarter of 2019, the company expanded SofPulse® commercialization and announced the first…

FridayOct 18, 2019 3:00 pm

QualityStocksNewsBreaks – Xalles Holdings Inc. (XALL) Becoming Leading Provider of Payment Systems by Acquiring, Mentoring Fintech Firms

Xalles Holdings (OTC: XALL), a business-development company focused on the payment industry and financial technology, is developing a fintech transaction-support strategy through acquisitions and mentoring. An article discussing the company further reads, “Xalles Holdings is working to become the dominant provider of payment systems by acquiring and mentoring select fintech firms with developing revenue streams and opportunities to boost those revenues. The company’s subsidiaries provide or are preparing to provide investment-management capabilities, post-payment auditing using a proprietary software platform, payment-card financial services and rewards programs that include nonprofit fundraising platforms, among other things. . . . ‘The common element .…

FridayOct 18, 2019 2:33 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) DehydraTECH Platform Offers Alternative to Traditional Inhalation

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative DehydraTECH(TM) platform works to deliver chemical compounds to the bloodstream at speeds similar to inhalation methods, offering an alternative to smoking. An article discussing the company further reads, “Lexaria’s noncombustion-based, noninhalation-based delivery method requires no chemicals or additives. . . . ‘We use a patented dehydration synthesis process to combine the nicotine with simple ingredients like sunflower oil in a unique way,’ CEO Chris Bunka told Forbes (http://ibn.fm/uCoMP). ‘It allows for the removal of the bitter taste often associated with nicotine without the need for artificial flavors that are often appealing to children.…

FridayOct 18, 2019 1:52 pm

QualityStocksNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Establishing Leadership in Booming Hemp-Derived, CBD-Oil Market

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) is making a name for itself as a market leader while the global hemp-derived CBD oil market is projected to reach $22 billion by 2022 (http://ibn.fm/yPoHn). An article discussing the company reads, “Following the latest strategic partnerships and retail collaborations, the Wildflower Brands CBD-infused products can now be found in 600 locations across America. . . . The marketplace is forecast to explode in the near future, and the entities that have an already well-established and recognizable brand will benefit the most, as McLean stated in a news release. ‘Our strategy is to build off…

FridayOct 18, 2019 1:46 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Launches Luxury Hemp-Based Product Line

Geyser Brands (TSX.V: GYSR), a global science-led, consumer, health-care company, recently launched a luxury hemp-based product line. An article discussing the company reads, “STōND is a line of 100% natural self-care products formulated with cannabis sativa hemp oil and features a wide range of products such as massage oils, body lotions, body scrubs, lip balms, mud masks, headache roll-ons, pain gels, joint creams, solid face serums and anti-wrinkle serums. . . . In a press release announcing the new line of products, the company noted that hemp is a source of potent polyunsaturated fats that play a key role in…

FridayOct 18, 2019 12:33 pm

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Projects Up to $180M in Net Revenues for FY2020

In a YouTube interview, Supreme Cannabis CEO Navdeep Dhaliwal stated that investors should focus on the company’s strong balance sheet Supreme Cannabis reported $41.8 million in sales for FY2019, as compared to $8.9 million in FY2018, marking a 370 percent year-over-year jump; the company also reported its first positive adjusted EBITDA Dhaliwal further noted that the performance of subsidiary 7ACRES is key to the company’s growth The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies, projects that its fiscal 2020 net revenues will increase to an estimated $150 million to $180…

FridayOct 18, 2019 12:25 pm

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Details New Strategic Plan to Cut Financing Requirements while Preserving Path to Profitability

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced its new strategic plan to reduce its financing requirements while maintaining its path to profitability. Per the update, the company intends to improve agility by reducing capital requirements, establishing a simple way to scale up production as more retail locations open and legal sales increase, and adapting to slower legal market conversion by deferring excess capacity and expenses. TGODF also maintains its objective to become EBITDA and operating cash flow positive by Q2 2020. “These actions are logical next steps in…

Site Search

Company Search